Document Type : Original Article

Author

Department of Animal Health and Welfare, College of Health and Biotechnology, Semyung University, Jecheon, South Korea

Abstract

Acute pancreatitis (AP) can develop into life-threatening conditions such as systemic inflammatory response syndrome (SIRS) or multiple organ dysfunction syndrome. Thirty-nine of 54 client-owned dogs admitted to the Referral Animal Medical Center and diagnosed with AP within 24 hr of onset were retrospectively reviewed to assess early predictors of progression from AP to SIRS. The patients were divided into SIRS (SIRS occurring after AP) and non-SIRS (AP occurring but no SIRS) groups. The population and mean values of laboratory variables within 24 hr of admission were assessed and compared between both groups. There were significantly more dogs with abnormal lactate levels in the SIRS group (80.00%) than non-SIRS group (11.10%). Other parameters did not differ significantly. Mean lactate level values were significantly higher at 3.64 ± 1.75 mmol in the SIRS group compared to 1.68 ± 0.52 mmol in the non-SIRS group. The increased energy required by activated immune cells may lead to metabolic changes characterized by anaerobic glycolysis and increased lactate production. This study’s results suggest blood lactate monitoring in the early stages of progression from AP to SIRS in small animal clinical practice. Measuring lactate levels at the early stages of pancreatitis could lead to rapid therapeutic intervention for SIRS and ultimately reduce mortality.

Keywords

Main Subjects

  1. Xenoulis PG. Diagnosis of pancreatitis in dogs and cats. J Small Anim Pract 2015; 56(1): 13-26.
  2. Zhang XP, Wang L, Zhou YF. The pathogenic mechanism of severe acute pancreatitis complicated with renal injury: a review of current knowledge. Dig Dis Sci 2008; 53(2): 297-306.
  3. AK, Breitschwerdt EB, Levine JF, et al. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985-1990). J Am Vet Med Assoc 1993; 203(5): 673-679.
  4. Schaer M. A clinicopathologic survey of acute pancreatitis in 30 dogs and 5 cats. J Am Anim Hosp Assoc 1979; 15(6): 681-687.
  5. Hirota M, Sugita H, Maeda K, et al. Concept of SIRS and severe acute pancreatitis [Japanese]. Nihon Rinsho 2004; 62(11): 2128-2136.
  6. Mansfield C. Pathophysiology of acute pancreatitis: potential application from experimental models and human medicine to dogs. J Vet Intern Med 2012; 26(4): 875-887.
  7. Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190(2): 117-125.
  8. Choi SW, Kim YH, Kang MS, et al. Serum concentration of inflammatory cytokines in dogs with suspected acute pancreatitis. Vet Sci 2021; 8(3): 51. doi: 10.3390/vetsci8030051.
  9. Karlsson I, Hagman R, Johannisson A, et al. Cytokines as immunological markers for systemic inflammation in dogs with pyometra. Reprod Domest Anim 2012; 47(Suppl 6): 337-341.
  10. Kakafika A, Papadopoulos V, Mimidis K, et al. Coagulation, platelets, and acute pancreatitis. Pancreas 2007; 34(1): 15-20.
  11. Rosenstein PG, Tennent-Brown BS, Hughes D. Clinical use of plasma lactate concentration. Part 1: physiology, pathophysiology, and measurement. J Vet Emerg Crit Care (San Antonio) 2018; 28(2): 85-105.
  12. Sharkey LC, Wellman ML. Use of lactate in small animal clinical practice. Clin Lab Med 2015; 35(3): 567-577.
  13. Manosalva C, Quiroga J, Hidalgo AI, et al. Role of lactate in inflammatory processes: friend or foe. Front Immunol 2022; 12: 808799. doi: 10.3389/fimmu.2021.808799.
  14. Dossin O. Laboratory tests for diagnosis of gastro-intestinal and pancreatic diseases. Top Companion Anim Med 2011; 26(2): 86-97.
  15. Kathrani A, Steiner JM, Suchodolski J, et al. Elevated canine pancreatic lipase immunoreactivity concentration in dogs with inflammatory bowel disease is associated with a negative outcome. J Small Anim Pract 2009; 50(3): 126-132.
  16. Simpson KW, Simpson JW, Lake S, et al. Effect of pancreatectomy on plasma activities of amylase, isoamylase, lipase, and trypsin-like immunoreactivity in dogs. Res Vet Sci 1991; 51(1): 78-82.
  17. Xenoulis PG, Steiner JM. Canine and feline pancreatic lipase immunoreactivity. Vet Clin Pathol 2012; 41(3): 312-324.
  18. Mansfield CS, Jones BR. Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases. Aust Vet J 2000; 78(6): 416-422.
  19. Wan J, Yang X, He W, et al. Serum D-dimer levels at admission for prediction of outcomes in acute pancreatitis. BMC Gastroenterol 2019; 19(1): 67. doi: 10.1186/s12876-019-0989-x.
  20. Zhang G-Q, Wang G, Li L, et al. Plasma D-dimer level is an early predictor of severity of acute pancreatitis based on 2012 Atlanta classification. Med Sci Monit 2019; 25: 9019-9027.
  21. Goebel PJ, Williams JB, Gerhardt RT. A pilot study of the performance characteristics of the D-dimer in presumed sepsis. West J Emerg Med 2010; 11(2): 173-179.
  22. Nielsen L, Holm J, Rozanski E, et al. Multicenter investigation of hemostatic dysfunction in 15 dogs with acute pancreatitis. J Vet Emerg Crit Care (San Antonio) 2019; 29(3): 264-268.